NCT01067079

Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen

A Phase III, Single Center, Open Label, Follow-up Immunogenicity Study in Subjects Who Previously Received Post-exposure Rabies Vaccine According to the Essen or 2:1:1 (Zagreb) Schedule

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 200 (actual)
• Sponsor: Novartis Vaccines · Industry
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

This study will evaluate the immunogenicity of rabies vaccine at 13 months, 3 year and 5 years after initial vaccination, administered in two different post-exposure vaccination schedules

Conditions

• Rabies

Interventions

Type	Name	Description
OTHER	No vaccine administered; subjects only have blood sampling for immunogenicity	No vaccine administered; subjects only have blood sampling for

Timeline

• Start date: 2010-01-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2010-02-11
• Last updated: 2011-12-30

Locations

1 site across 1 country: China